The Bureau of Economic Analysis today updated its supplemental health care statistics with an improved methodology that shows the growing role of prescription drug rebates over two decades. After subtracting the rebates, BEA's estimate of health care spending in 2020 was reduced by $158 billion, or 5.3 percent, from the previous estimate for 2020.
The Health Care Satellite Account measures spending on treatment of medical conditions, such as cancer or diabetes. This more-detailed, disease-centered view supplements BEA's traditional economic statistics for a deeper understanding of health care spending patterns and policies.